Mafraq Hospital and Masimo (NASDAQ: MASI) jointly announced the hospital-wide conversion of Mafraq Hospital to Masimo rainbow SET Pulse CO-OximetryTM technology for advanced noninvasive patient monitoring capabilities.
The conversion makes Mafraq Hospital the first hospital in the UAE to feature Masimo’s technologically and clinically-advanced oximetry and noninvasive patient monitoring solutions, according to a joint press release.
The Masimo rainbow SET Pulse CO-Oximetry technology platform allows hospitals to noninvasively measure and continuously monitor multiple blood constituents and physiological parameters that previously required invasive procedures including: total hemoglobin (SpHb ), oxygen content (SpOCTM), carboxyhemoglobin (SpCO ), methemoglobin (SpMet ), Pleth Variability Index (PVI ), and acoustic respiration rate (RRaTM), in addition to the �gold-standard’ Measure-Through Motion and Low Perfusion performance of Masimo SET oxyhemoglobin (SpO2), perfusion index (PI), and pulse rate (PR). The oximetry standard-of-care at leading hospitals worldwide, Masimo rainbow SET provides immediate real-time results that enable clinicians to more rapidly assess patients and detect and treat adverse, potentially life-threatening conditions earlier.
“Mafraq Hospital takes great pride in the skills and experience of its physicians and the fact that we have some of the world’s most advanced equipment available, so that we can provide the best medical care and treatment services in one of the fastest growing areas in the Emirate of Abu Dhabi,” stated John Nickens, CEO at Mafraq Hospital. “We saw tremendous value in the superior performance and futuristic noninvasive capabilities of Masimo rainbow SET Pulse CO-Oximetry and wanted to extend its positive clinical impact and patient care benefits to all of our patients throughout the hospital.” Mafraq Hospital, managed by Bumrungrad International and owned and operated by the Abu Dhabi Health Services Company PJSC (SEHA), which is responsible for all the curative activities of public hospitals and clinics in Abu Dhabi, is a major referral hospital and comprehensive tertiary healthcare provider in the UAE for 510,000 patients each year. The conversion ensures that all multiparameter patient monitors, stand-alone oximeters, and sensors throughout the hospital will feature the advanced noninvasive patient monitoring capabilities of Masimo rainbow SET allowing Mafraq Hospital clinicians to easily and painlessly obtain and continuously track vital blood and physiological data for patients in real-time. Mafraq Hospital initially launched the new technology platform hospital-wide with Masimo SET pulse oximetry measurements (SpO2, PI, and PR), enabling the hospital to quickly and easily upgrade to Masimo rainbow Pulse CO-Oximetry measurements (SpHb, SpOC, PVI, SpCO, SpMet) as needed.
According to Mafraq Hospital Chief Nursing Officer, Gail Smith, “This conversion provides an exciting new medical first noninvasive and continuous hemoglobin (SpHb), which allows our clinicians to perform trauma-free hemoglobin blood tests and get immediate results. And, as the only hospital in the UAE equipped with SpHb, we not only have the ability to quickly measure hemoglobin levels without removing a drop of blood from the patient, but we can now continuously track hemoglobin levels in real-time without having to perform repeated, painful blood draws and time-consuming lab analyses.” Masimo Founder and CEO, Joe Kiani, stated, “We are happy to be partnering with Mafraq Hospital as they lead the UAE in advancing the care and safety of patients. Mafraq Hospital’s adoption of Masimo rainbow SET now makes it possible for hospital clinicians to noninvasively monitor and continuously track key indicators of a patient’s relative physiological status including hemoglobin and other blood constituents as well as fluid volume and respiration rate to immediately and painlessly identify abnormalities and detect potentially life-threatening conditions much earlier.” The CEO of Emitac Healthcare Solutions (EHS), Masimo’s distributor in the UAE, Mr. Raghavan Srinivasan considers it a matter of pride to partner with Masimo in deploying this solution to Mafraq Hospital, stating that: “This is a progressive step by the hospital to adopt innovative means to providing quality healthcare in the country.”
WAM